BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37915905)

  • 21. Incidence, predictors and 6-month overall outcome of acute kidney injury in Chinese patients receiving PD-1 inhibitors.
    Qin Z; Liu K; Xu X; Li T; Ge Y; Wu B; Xing C; Mao H
    Future Oncol; 2022 May; 18(16):1951-1962. PubMed ID: 35232231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPIs and kidney disease: from AIN to CKD.
    Moledina DG; Perazella MA
    J Nephrol; 2016 Oct; 29(5):611-6. PubMed ID: 27072818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell Carcinoma.
    Yin J; Elias R; Peng L; Levonyak N; Asokan A; Christie A; Kubiliun N; Brugarolas J; Hammers HJ
    Clin Genitourin Cancer; 2022 Jun; 20(3):260-269. PubMed ID: 35277350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis, management, and outcomes of immune checkpoint inhibitor induced acute interstitial nephritis: A single-center experience.
    Elghawy O; Patel R; Barsouk A; Puthumana J; Xu J; Sussman J; Horton B; Kaur V
    J Oncol Pharm Pract; 2024 May; ():10781552241252627. PubMed ID: 38706192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
    Liu C; Wei W; Yang L; Li J; Yi C; Pu Y; Yin T; Na F; Zhang L; Fu P; Zhao Y
    Front Immunol; 2023; 14():1173952. PubMed ID: 37313406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis.
    Sise ME; Wang Q; Seethapathy H; Moreno D; Harden D; Smith RN; Rosales IA; Colvin RB; Chute S; Cornell LD; Herrmann SM; Fadden R; Sullivan RJ; Yang NJ; Barmettler S; Wells S; Gupta S; Villani AC; Reynolds KL; Farmer J
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Systematic Review of Immune Checkpoint Inhibitor-Associated Glomerular Disease.
    Kitchlu A; Jhaveri KD; Wadhwani S; Deshpande P; Harel Z; Kishibe T; Henriksen K; Wanchoo R
    Kidney Int Rep; 2021 Jan; 6(1):66-77. PubMed ID: 33426386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma.
    Marco T; Anna P; Annalisa T; Francesco M; Stefania SL; Stella D; Michele R; Marco T; Loreto G; Franco S
    Ther Adv Med Oncol; 2019; 11():1758835919875549. PubMed ID: 31579108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.
    Seethapathy H; Zhao S; Chute DF; Zubiri L; Oppong Y; Strohbehn I; Cortazar FB; Leaf DE; Mooradian MJ; Villani AC; Sullivan RJ; Reynolds K; Sise ME
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1692-1700. PubMed ID: 31672794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune checkpoint inhibitors induce acute interstitial nephritis in mice with increased urinary MCP1 and PD-1 glomerular expression.
    Martinez Valenzuela L; Gómez-Preciado F; Guiteras J; Antón Pampols P; Gomà M; Fulladosa X; Cruzado JM; Torras J; Draibe J
    J Transl Med; 2024 May; 22(1):421. PubMed ID: 38702780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facing the Challenge of Drug-Induced Acute Interstitial Nephritis.
    Sanchez-Alamo B; Cases-Corona C; Fernandez-Juarez G
    Nephron; 2023; 147(2):78-90. PubMed ID: 35830831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience.
    Oleas D; Bolufer M; Agraz I; Felip E; Muñoz E; Gabaldón A; Bury R; Espinel E; Serón D; García-Carro C; Soler MJ
    Clin Kidney J; 2021 May; 14(5):1364-1370. PubMed ID: 34221369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compartmentalization of Intrarenal Programmed Cell Death Protein 1-Ligand 1 and Its Receptor in Kidney Injury Related to Immune Checkpoint Inhibitor Nephrotoxicity.
    Tampe D; Kopp SB; Baier E; Hakroush S; Tampe B
    Front Med (Lausanne); 2022; 9():902256. PubMed ID: 35755033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors.
    Zheng Y; Kim R; Yu T; Gayle JA; Wassel CL; Dreyfus J; Phatak H; George S
    Oncologist; 2021 Nov; 26(11):e2002-e2012. PubMed ID: 34327774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors and prognostic role of renal adverse event in patients receiving immune checkpoint inhibitor therapy: analysis of data from a retrospective cohort study.
    Bao Z; Luo L; Xu T; Yang J; Lv M; Ni L; Sun X; Chen W; Zhou L; Wang X; Xiang Y; Gao B
    Ann Transl Med; 2022 Sep; 10(18):967. PubMed ID: 36267724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population-based cohort study.
    Munch PV; Nørgaard M; Heide-Jørgensen U; Jensen SK; Birn H; Christiansen CF
    Int J Cancer; 2024 Apr; 154(7):1164-1173. PubMed ID: 37983738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury.
    Sprangers B; Leaf DE; Porta C; Soler MJ; Perazella MA
    Nat Rev Nephrol; 2022 Dec; 18(12):794-805. PubMed ID: 36168055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biopsy-proven acute interstitial nephritis, 1993-2011: a case series.
    Muriithi AK; Leung N; Valeri AM; Cornell LD; Sethi S; Fidler ME; Nasr SH
    Am J Kidney Dis; 2014 Oct; 64(4):558-66. PubMed ID: 24927897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune checkpoint inhibitors in patients with chronic kidney disease: Assessing their ability to cause acute kidney injury and informing their proper use.
    Min JW; Lim JU
    Semin Oncol; 2022 Apr; 49(2):141-147. PubMed ID: 35264308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, mortality, and risk factors of acute kidney injury after immune checkpoint inhibitors: Systematic review and meta-analysis of real-world evidence.
    Xie W; Xiao S; Li X; Huang J; Li G; Zhang Z
    Eur J Intern Med; 2023 Sep; 115():88-95. PubMed ID: 37263805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.